| 영문 | vaccinia | 한글 | 우두 |
|---|---|---|---|
| 설명 | 1. 마마 백신의 접종으로 나타나는 피부 반응으로서 때때로 전신적인 반응으로도 나타난다. 2. 원칙적으로 소의 발진성바이러스병이다. 사람에게는 우두바이러스의 접종으로 국소 농포성 발진이 생기며, 우두를 앓은 지 얼마 안되는 소의 우유를 짠 사람, 병든 소, 우사牛舍에 깐 짚 등에서 감염한다. 진단은 임상증세부터 살핀다. 환부의 소독이 충분하면 병터는 10~15일 만에 낫는다. 사람의 종두에는 이 병원체가 쓰인다. 접종 후에는 우두바이러스의 감염, 세균에 의한 이차 감염 혹은 감염 후 수막뇌염 등의 국소 혹은 전신 합병증이 자주 생긴다. |
||
| 영문 | congenital syphilis | 한글 | 선천매독 |
|---|---|---|---|
| 설명 | 임부가 매독에 감염되어 있으면 임신 후기에 매독균이 태반을 통해 혈행성으로 태아에 감염(수직감염)된 것을 말하다. 대부분은 유산, 사산이 되지만 출생하면 제2기 이후의 발진을 보인다. 발현시기에 따라서 ① 태아매독, ② 유아매독, ③ 만발성 선천매독으로 분류된다. ①에서는 뼈연골염, 간-지라 비대와 매독성 천포창, ②에서는 파로가성마비와 매독성 코염, ③에서는 허친슨 세징후(허친슨 치아, 속귀성 난청, 실질성 각막염)에 따라 특징이 있다. 기타 수두증, 지능발육 불량 등을 자주 볼 수 있다. 매독 혈청반응은 대부분의 경우 양성으로 나온다. 매우 드물게 간세포내에서 매독균을 무수히 볼 수 있다. 간세포 주변의 섬유화와 함께 불규칙한 흉터(hepar lobatum)를 만들 수 있다. |
||
| 영문 | congenital rubella syndrome | 한글 | 선천풍진증후군 |
|---|---|---|---|
| 설명 | 임신기간 중에 산모가 풍진에 걸리면 이 풍진 바이러스는 태반을 통해서 태아에게 전달되어서 태아의 풍진감염을 일으킨다. 임신 첫 3개월 동안, 특히 임신 첫달에 태아가 풍진의 감염을 받으면, 신생아에서 선천기형, 즉 눈에서 촛점을 정확히 맞추어주는 렌즈의 역할을 하는 수정체의 혼탁(백내장), 심장기형, 귀머거리 및 심한 지능박약을 동반하는 소두증 등이 발생하는 수가 많다. |
||
| 영문 | congenital heart disease | 한글 | 선천심장병 |
|---|---|---|---|
| 설명 | 선천적으로 심장의 구조에 이상이 있는 병. |
||
| CDH | 1) Chronic Daily Headache = CTH = ... |
|---|---|
| CDH | ceramide dihexoside; congenital diaphragmatic hernia; congenital dislocation of hip; congenital dysp... |
| VIG, VIg | vaccinia immunoglobulin |
| VV | vaccinia virus; varicose veins; veno-venous; viper venom; vulva and vagina |
| CAV | congenital absence of vagina; congenital adrenal virilism; constant angular velocity; croup-associat... |
| MVA | Modified Vaccinia Ankara |
|---|---|
| MVA | Modified Vaccinia Virus Ankara |
| RVV | Recombinant vaccinia virus |
| VMO | Vaccinia Melanoma Oncolysates |
| VAC | Vaccinia virus |
| bovine vaccinia mammillitis | A poxlike disease of the skin of the bovine teat caused by vaccinia virus. (05 Mar 2000) |
|---|---|
| vaccinia | <dermatology> The cutaneous and sometimes systemic reactions associated with vaccination with smallpox vaccine. (18 Nov 1997) |
| vaccinia gangrenosa | A severe or even fatal form of vaccinia occurring chiefly in subjects with an immunologic deficiency or dyscrasia and characterised by progressive enlargement of the initial and also of secondary lesions. Synonym: vaccinia gangrenosa. (05 Mar 2000) |
| vaccinia virus | <molecular biology, virology> DNA viruses used in several biotechnology applications, including expression vector systems. Because they can hold quite a lot of DNA, they can be used to make more than one protein at once in a cell, which can be useful for making proteins with more than one polypeptide chain. (14 Nov 1997) |
| variola vaccinia | <dermatology> The cutaneous and sometimes systemic reactions associated with vaccination with smallpox vaccine. (18 Nov 1997) |
| generalised vaccinia | Secondary lesions of the skin following vaccination which may occur in subjects with previously healthy skin but are more common in the case of traumatised skin, especially in the case of eczema (eczema vaccinatum). In the latter instance, generalised vaccinia may result from mere contact with a vaccinated person. Secondary vaccinial lesions may also occur following transfer of virus from the vaccination to another site by means of the fingers. (05 Mar 2000) |
| progressive vaccinia | A severe or even fatal form of vaccinia occurring chiefly in subjects with an immunologic deficiency or dyscrasia and characterised by progressive enlargement of the initial and also of secondary lesions. Synonym: vaccinia gangrenosa. (05 Mar 2000) |
| adrenal hyperplasia, congenital | A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form. (12 Dec 1998) |
| anaemia, dyserythropoietic, congenital | A familial disorder characterised by anaemia with multinuclear erythroblasts, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors. Type II is the most common of the 3 types of congenital dyserythropoietic anaemia; it is often referred to as hempas, based on the hereditary erythroblast multinuclearity with positive acidified serum test. (12 Dec 1998) |
| anaemia, haemolytic, congenital | Haemolytic anaemia due to various intrinsic defects of the erythrocyte. (12 Dec 1998) |
| anaemia, haemolytic, congenital nonspherocytic | Any one of a group of congenital haemolytic anaemias in which there is no abnormal haemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated. (12 Dec 1998) |
| bovine congenital ataxia | An autosomal recessive ataxia seen in several European breeds of cattle. (05 Mar 2000) |
| bullous congenital ichthyosiform erythroderma | Diffusely red, eroded skin at birth, with subsequent scaling, tending to improve in later life, characterised by generalised epidermolytic hyperkeratosis and autosomal dominant inheritance. See: epidermolytic hyperkeratosis. Synonym: generalised epidermolytic hyperkeratosis, ichthyismus hystrix, ichthyosis hystrix. (05 Mar 2000) |
| pain insensitivity, congenital | Absence of sensibility to pain or inability to feel pain. The condition is present at birth. (12 Dec 1998) |
| rubella syndrome, congenital | Transplacental infection of the foetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalised growth retardation. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|